Lottery.com Inc
Change company Symbol lookup
Select an option...
LTRY Lottery.com Inc
RCLF Rosecliff Acquisition Corp I
SSYS Stratasys Ltd
GRN iPath? Series B Carbon ETN
RCKTF Rock Tech Lithium Inc
SOND Sonder Holdings Inc
PTE PolarityTE Inc
CTRA Coterra Energy Inc
L Loews Corp
HSY Hershey Co
Go

*Nasdaq FSI: *Deficient and Delinquent: Issuer Failed to Meet NASDAQ Continued Listing Requirements, and Missed Regulatory Filing Deadline

Company profile

Lottery.com Inc. is a technology company that is a provider of domestic and international lottery products and services. It is engaged in mobile and online platforms that enable players located in the United States and internationally to remotely purchase legally sanctioned lottery games. The Company offers the platform through the Lottery.com app and its Websites to users located in the United States. and international jurisdictions where the sale of lottery games is legal, and its services are enabled for the remote purchase of legally sanctioned lottery games (B2C Platform). It offers an internally developed, created and operated business-to-business application programming interface (API) of the platform to enable commercial partners in permitted the United States and international jurisdictions to purchase certain legally operated lottery games from the Company and resell them to users located within their respective jurisdictions (B2B API). It also delivers global lottery data.

Price
Delayed
$0.2501
Day's Change
0.011 (4.60%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.2501
Day's Low
0.2319
Volume
(Average)

Today's volume of 32,384 shares is on pace to be in-line with LTRY's 10-day average volume of 429,844 shares.

32,384

GLOBAL BLOOD THERAPEUTICS, INC. ALERT: Bragar Eagel & Squire, P.C. Investigates Merger of GBT and Encourages Investors to Contact the Firm

4:48 pm ET August 9, 2022 (Globe Newswire) Print

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors of Global Blood Therapeutics, Inc. (NASDAQ: GBT) ("GBT") breached their fiduciary duties or violated the federal securities laws in connection with the company's acquisition by Pfizer Inc. (NYSE: PFE) ("Pfizer").

Click here to learn more and participate in the action.

On August 8, 2022, GBT announced that it had entered into an agreement to be acquired by Pfizer in an all-cash deal with an enterprise value of $5.4 billion. Pursuant to the merger agreement, Pfizer will acquire all the outstanding shares of GBT for $68.50 per share in cash. The deal is scheduled to close as early as the fourth quarter of 2022.

Bragar Eagel & Squire is concerned that GBT's board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for GBT's stockholders.

If you own shares of GBT and are concerned about the proposed merger, or you are interested in learning more about the investigation or your legal rights and remedies, please contact Melissa Fortunato by email at mergers@bespc.com or telephone at (646) 860-9157, or by filling out this contact form. There is no cost or obligation to you.

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:

Bragar Eagel & Squire, P.C.

Melissa Fortunato, Esq.

mergers@bespc.com

www.bespc.com

https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg

https://ml.globenewswire.com/media/29481954-f2ff-4756-b5a9-d982a6497bd0/small/bes-mark-jpg.jpg

comtex tracking

COMTEX_411942337/2010/2022-08-09T16:48:48

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.